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ABSTRACT
Long QT Syndrome (LQTS), a disorder of the cardiac repolarization process with
prolongation of the QT interval (QTc ≥0.46 seconds), is an ion-channelopathy. Mutations
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in either KCNQ1 or KCNE1 genes are susceptible to LQTS. Hence, screening of KCNQ1
and KCNE1 genes is taken up to evaluate the genetic correlation of these genes in Long
QT patients of Indian origin.
A total of 33 Long QT Syndrome patients and 100 healthy subjects were enrolled for the
present study. PCR-SSCP protocol was utilised for screening of KCNQ1 and KCNE1
genes followed by In-silico and statistical analysis.
The clinical profile of the Long QT syndrome patients in our study revealed a higher
percentage of females with the mean age also being higher in females when compared
to males. The two variations (S546S and IVS13+36A>G) in KCNQ1 and the S38G
polymorphism in KCNE1 gene were identified and their association with Long QT
syndrome is being reported for the first time in Indian population. S546S is located in
the KCNQ1 C terminus close to this domain and IVS13+36A>G is located in the intronic
region in close proximity to the coding region for C-terminal domain; these may therefore
affect the functional protein through non-assembly. S38G leads to a substitution of serine
to glycine at 38th amino acid position (S38G) in the transmembrane domain of KCNE1.
Our study reports compound heterozygosity/genetic compound ofS546S and
IVS13+36A>G of KCNQ1 gene. Haplotype frequencies and linkage disequilibrium
analysis revealed a significant association between the three biomarkers. Compound
heterozygosity of the polymorphisms influence downstream signalling and KCNQ1-
KCNE1 interactions.
Keywords: Long QT syndrome; compound heterozygotes; KCNQ1; KCNE1; linkage
disequilibrium; C-terminal domain.
1. INTRODUCTION
Long QT Syndrome (LQTS), a congenital disorder, characterized by prolongation of the QT
interval (QTc ≥0.46 seconds) affects 1 in 7,000 individuals of the general population.LQTS is
associated with recurrent syncope due to a transient, rapid, polymorphic ventricular
tachycardia, also known as torsade de pointes, and sudden death. Genetic investigations
demonstrated LQTS susceptibility genes to be of cardiac ion channels and/or regulatory
proteins involved in localization of sodium or calcium channels to the sarcolemma, hence,
long QT syndrome is a disease of ion channel dysfunction [1].
The voltage-gated potassium channel, KQT-like subfamily, member 1 (KCNQ1), encodes
pore-forming voltage gated K+ channel subunit KvLQT1 and is widely expressed in
myocardial tissue. Hence it plays a key role in repolarization of the cardiac action potential
and transport of water and salt in epithelial tissues. [2] Each KCNQ1 subunit has six
transmembrane segments (S1–S6), with S1–S4 segments serving as a voltage-sensor
domain, S5–S6 segments forming a pore domain and four KCNQ1 subunits forming the ion
channel [3]. KCNQ1 channels only form homotetramers and function in non-excitable as well
as excitable tissues. KCNQ1 channels co-assemble with KCNE1 peptides, affording a
complex with different gating properties and pharmacological sensitivities. The KCNQ1-
KCNE1 complex generates cardiac IKs current in the heart and provides an avenue for K+ to
enter the endolymph in inner ear [4]. The biophysical properties of the KCNQ1 current are
dramatically altered when its subunit associates with KCNE1.Mutations in KCNQ1 or KCNE1
maybe fatal for life-threatening cardiac arrhythmias [5,6,7,8,9].
KCNQ1 gene is localised to 11p15.5, and mutations in the KCNQ1 gene result in type-1
long-QT syndrome. Analysis of the gene demonstrated a truncated isoform, which encodes
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a 549-amino acid protein [10]. KCNE1 is a 129-amino acid minK protein containing one
transmembrane-spanning domain. It is encoded by KCNE1 gene located at 21q22.1-22.2
which is implicated in LQT type-5 [11,12]. Mutations in the KCNQ1 gene account for the vast
majority of congenital LQTS with most missense mutations being located in the conserved
core domain of the protein and in the cytoplasmic C-terminal domain. Functional expression
studies have shown that mutations within the core domain of the KvLQT1 protein seem to
cause loss of function and dominant-negative effect. A P-domain mutation with a very mild
functional effect has also been reported. One C-terminal mutation, R555C, has been
associated with a ‘formefruste’ of LQTS that leads to a functional channel with an altered
voltage-dependence [13].
Mutations in either KCNQ1 or KCNE1 decrease the conductance of the complex and prolong
the cardiac action potential, leaving individuals with these mutant proteins susceptible to
long QT syndrome. Hence, this study focuses on screening KCNQ1 and KCNE1 genes in
Indian population to understand the genetic correlation of these genes in patients with Long
QT syndrome. We report two variations in KCNQ1 and a polymorphism in KCNE1 genes
and their pathogenic potential was examined by In-silico analysis.
2. METHODOLOGY
2.1 Study Subjects
Blood samples were collected for molecular analyses from confirmed 33 LQTS probands
and their available family members from Care Hospitals, Hyderabad, Sri Jayadeva Institute
of Cardiovascular Science and Research, Bangalore and Institute of Maternal and Child
Health,Calicut Medical College, Calicut. This study has been approved by the Institutional
Ethics Committee, Dept. of Genetics, Osmania University, Hyderabad and informed written
consent was obtained from the probands and their family members. Blood samples from 100
controls (50 M: 50 F), without any history of cardiovascular or systemic conditions, were
collected from Osmania General Hospital, Hyderabad for comparative analysis.
2.2 Molecular Analyses
Genomic DNA was isolated from peripheral blood samples by standard protocols in 100
controls, 33 probands and their family members. The DNA sequences corresponding to
KCNQ1 and KCNE1 genes were amplified using the primer sets as described by Syrris et al
[14]. Fragments were amplified on Eppendorf Thermal cycler Gradient in the presence of 1 U
Taq DNA polymerase, 0.2 mMdeoxyribonucleotide, 1.5 mM MgCl2, 100 ng forward andreverse primers and genomic DNA. The PCR products were subsequently screened by
Single Stranded Conformational polymorphism (SSCP) according to standard procedures
and the gels were visualized by silver-staining. The variations observed, were confirmed by
commercial sequencing (HiSeq 2000 sequencing machine, Illumina, CA).
2.3 Statistical Analysis
Fisher's exact test and odds risk estimate were computed for possible genotype association.
Interactive SNPs were analyzed by means of logistic regression (OR) to determine the
significance of risk genotypes at 95% confidence interval (CI) followed by haplotype
frequency computation by the EM algorithm using SNPstat software [15]. Linkage
disequilibrium was inferred by Haploview software [16].
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2.4 In-Silico Analysis
In-silico analysis was also carried out to elucidate the mRNA secondary structure changes
(GENEBEE software), splice site changes (www.cbs.dtu.dk/services/NetGene2/), possible
binding site variations for SnRNP’s involved in spliceosome formation
(http://sfmap.technion.ac.il/) and possible changes in protein primary structure
(http://asia.ensembl.org) that resulted due to the observed exonic variations.
3. RESULTS
3.1 Clinical Profile
Data presented in Table 1 indicates mean age of 18.2 ±15.7yrs in males and females at 22
±16.6 yrs in LQTS patients. 36.36% of the males exhibited Long QT syndrome when
compared to 63.63% of females. The mean age at onset in all the Long QT syndrome
patients was found to be 17.6 ±17.4yrs. 27.27% of the patients exhibited consanguinity and
history of sudden deaths in their family. Clinical profile indicated that 63.63% of the patients
had an episode of syncope and 9.09% were deaf. Mean QTc interval was found to be 493 ±
45.8 msec in males and 476 ± 51.7 msec in females. Patients with acquired Long QT
Syndrome (aLQTS), exhibited hypokalemia with the serum potassium levels as low as 3.3
mmol/L. 84.84% of our patients were non-vegetarian.
Table 1. Comparison of epidemiological variables in controls and LQTS patients
Variable Controls n(%) LQTS patients n(%)
aLQTS
cLQTS
- aLQTS – 6 (18.18%)
cLQTS - 27 (81.81%)
Gender Females-21 (63.63%)
Males-12 (36.36%)
Females-29.4 ± 10.6
Males-30.4 ± 8.07
Consanguinity - 9 (27.27%)
Nutrition Non-veg-89 (89%)
Veg-11 (11%)
Non-veg-28 (84.84%)
Veg-5 (15.15%)
Syncope - 21 (63.63%)
Deafness - 3 (9.09%)
F/h Sudden deaths - 9 (27.27%)
Variable Controls (Mean+SD) LQTS patients (Mean+SD)
QTc in msec Females- 410 Males-390 Females-476 ± 51.7
Males-493 ± 45.8
Age in yrs Females-29.4 ± 10.6
Males-30.4 ± 8.07
Females-22 ± 16.6
Males-18.2 ± 15.7
Age at onset in yrs - 17.6 ± 17.4
Serum potassium (mmol/L 3.4-5.5 3.3
3.2 Molecular Results
3.2.1 KCNQ1
PCR-SSCP analysis was carried out for all the 16 exons of KCNQ1 gene revealed variations
in exons 3, 4 and 13. Variations observed in exon 3 and 4 of KCNQ1 in a proband (P6) and
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his family members highlighting the hot spot of these exons [Qureshi et al, personal
communication].
PCR-SSCP analysis of exon 13 of KCNQ1 revealed 3 types of band patterns in both controls
and LQTS patients (Fig. 1).
Fig. 1. SSCP pattern of Exon-13 of KCNQ1
Samples for each band pattern on commercial sequencing revealed 2 SNPs:
 G > A transition at 2737237 in Exon 13 leading to a neutral substitution S546S –
rs1057128 (Fig. 2) and
 A>G transition at 2737320 in Intron 14 -IVS13+36A>G(Fig. 2).
a) Electropherogram of Band pattern ‘I’ showing GG genotype of nt2737237 (S546S) and
IVS13+36A>G.
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b) Electropherogram of Band pattern ‘II’ showing AA genotype of nt2737237 (S546S) and
IVS13+36A>G
c) Electropherogram of Band pattern ‘III’ showing AG genotype of nt2737237 (S546S) and
IVS13+36A>G
Fig. 2.Electropherograms indicating the transition of G > A at 2737237 (S546) and A>G
at 2737320 (IVS13+36A>G)of KCNQ1 gene
Table 2 clearly indicates that an individual does not carry variant allele of both the
polymorphisms, instead each individual is found to carry wild type allele of one SNP and
variant allele of the other leading to compound heterozygosity/Genetic compound.
British Journal of Medicine & Medical Research, 3(4): 978-992, 2013
984
Table 2. Genotypes for S546S and IVS13+36A>G SNPs in controls and LQTS patients
Gene exon SNP Genotype of
band pattern
‘I’
Genotype of
band pattern
‘II’
Genotype of
band pattern
‘III’
KCNQ1 Exon 13 G > A
nt2737237
(S546S)
GG
(wild type)
AA
(variant)
AG
(heterozygote)
KCNQ1 Intron 14 IVS13+36A>G GG
(variant)
AA
(wild type)
AG
(heterozygote)
3.2.2 KCNE1 gene
KCNE1 gene has a single exon which is split into two fragments for analysis. The PCR-
SSCP analysis of the second fragment did not reveal any variation but the first fragment of
KCNE1 revealed a variation with three types of band patterns I, II, III (Fig. 3).
Fig. 3. SSCP pattern of 1st fragment of KCNE1
Commercial sequencing of samples for each band pattern revealed a transition A>G at
542position in KCNE1 single exon leading to a substitution of serine to glycine at 38th
position S38G- rs17846179 (Fig. 4).
British Journal of Medicine & Medical Research, 3(4): 978-992, 2013
985
Fig. 4. Electropherograms indicating the transition of 542 A>G (S38G) in KCNE1 gene
3.3 Statistical Analysis
For the S546S and IVS13+36A>GSNPs, the genotypic frequencies of AA, AG and GG were
found to be 5%, 55% and 40% in controls and 16%, 28% and 56% in LQTS patients
respectively. A higher frequency of the variant ‘AA’ (16%) genotype in LQTS patients was
observed when compared to controls (5%) indicating the preponderance of ‘A’ allele as a
risk allele. However, no significant difference was observed in the allelic frequency
distribution, indicating the gene pool to be in equilibrium (Table3). Odds risk estimates were
calculated using SNPSTAT software which generated four models. The odds ratio was found
to be 0.36folds higher for ‘AG’ when compared to GG and AA genotypes (95% CI 0.15-0.89;
p = 0.014) (Table4).
The genotypic frequencies for the A>Gtransition at 542 position (S38G) were 4%, 55% and
41% in controls and 12%, 38% and 50% in LQTS patients respectively for AA, AG and GG
genotypes. Allelic frequencies were similar in LQTS patients and controls with the
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distribution being in equilibrium (Table3). Odds risk estimates of the genotypes did not reveal
any significant variation (Table4).
Table 3. Genotypic and allelic frequency distribution of the 3 polymorphisms in
controls and LQTS patients of KCNQ1
SNP Genotype Controls
n (%)
LQTS
patients
n (%)
Allele Controls LQTS
patients
S546S
(rs1057128) &
IVS13+36G>A
AA
AG
GG
5 (5)
55 (55)
40 (40)
5 (16)
9 (28)
18 (56)
G
A
0.68
0.32
0.7
0.3
S38G
(rs17846179)
AA
AG
GG
4 (4)
55 (55)
41 (41)
4 (12)
12 (38)
16 (50)
G
A
0.68
0.32
0.69
0.31
Table 4.Odds risk estimates of genotypes and alleles in LQTS patients compared to
control group for the 3 polymorphisms identified
SNP Model Genotype OR (95% CI) p value
S546S
(rs1057128)
&
IVS13+36A>G
Codominant GG          AG
AA
1.00
0.36 (0.15-0.89)
2.22 (0.57-8.65) 0.014
Dominant GG
AG/AA
1.00
0.52 (0.23-1.16)
0.11
Recessive GG/AG
AA
1.00
3.52 (0.95-13.06)
0.066
Overdominant GG/AA
AG
1.00
0.32 (0.13-0.76)
0.0072
G vs A 0.877(0.454-1.685) 0.79
S38G
(rs 17846179)
Codominant GG
AG
AA
1.00
0.56 (0.24-1.31)
2.56 (0.57-11.50)
0.11
Dominant GG
AG/AA
1.00
0.69 (0.31-1.55)
0.37
Recessive GG/AG
AA
1.00
3.43 (0.81-14.59)
0.1
Overdominant GG/AA
AG
1.00
0.49 (0.22-1.11)
0.084
G vs A 0.988(0.515-1.889) 1.00
p<0.05
3.4 Haplotype Frequencies & Linkage Disequilibrium (LD) Analysis
Haplotype frequencies for the various allelic combinations between the three polymorphisms
were computed for their possible association with LQTS (Table 5).Frequency of
GGGhaplotype was highest in controls (0.675) and LQTS patients (0.6385). Interestingly, the
GGA haplotype was present only in LQTS patients (0.0646). There was a significant
difference in the GGA haplotype frequency in patient group (p<0.0001) when compared to
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controls. The increased significance of the association of the GGA haplotype with Long QT
syndrome indicates a functional role of the compound haplotypes in disease susceptibility.
Table 5. Haplotype frequencies of the 3polymorphisms in controls and LQTS patients
Haplotype Haplotype frequency p
Controls LQTS patients
GGG 0.675 0.6385 -
AAA 0.315 0.2479 0.8
AAG 0.01 0.049 0.14
GGA NA 0.0646 <0.0001
p<0.05
A pair-wise comparison of the three polymorphisms, depicting the LD measures is
represented in Fig. 5. Significant D’ values were observed for the S546S
&IVS13+36A>GSNPs (D’=0.99), S546S and S38G (D’=0.92) and IVS13+36A>G and S38G
(D’=0.92),indicating a strong/tight linkage disequilibrium between the SNPs.
Fig. 5.Pairwise Linkage disequilibrium analysis of KCNQ1 and KCNE1 polymorphisms
3.5 In-silicoAnalysis
In case of S546S polymorphism, mRNA secondary structure prediction indicated that the
variation lead to a change in the secondary structure of mRNA with an increase in free
energy of the variant (-69.3 kkal/mol) when compared to the wild type (-73.7 kkal/mol). Due
to the variant allele, splicing factor binding sites were also found to vary for SRp40, NOVA1
with the formation of a new binding site for QK1 motif. These variations might alter the
downstream signalling, thus affecting the final stoichiometry of the protein. The 2737237G >
A transition in exon 13 leads to a neutral substitution of serine at 546th amino acid (S546S-
rs1057128) [17] encoding the C-terminus of KCNQ1 [10]. An increase in usage of codon
UCA (0.15) with a variant A allele when compared to codon UCG (0.05) was observed.
mRNA secondary structure prediction indicated that the intronic variation IVS13+36A>G lead
to a loss of stem-4 and formation of an aberrant stem-3 with a decrease in free energy of the
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variant (-80.0 kkal/mol) when compared to the wild type (-73.7 kkal/mol). The IVS13+36G>A
SNP variant allele caused variations in the splicing factor binding sites for SF2ASF, SC35
and hnRNPH/F motifs.
In case of S38G variant of KCNE1 gene, secondary mRNA structure prediction indicated
that the variation lead to a change in the free energy of stem 4 of secondary structure of
mRNA which in turn increased the free energy of the variant (-43.2 kkal/mol) when
compared to the wild type (-43.9 kkal/mol). The 542 A>G transition resulted in substitution of
serine to glycine at 38th amino acid position (S38G) wherein a polar, hydrophilic, essential
serine is being replaced by a non-polar, hydrophobic, non-essential glycine, as explained by
Dayhoff’s mutation odds matrix [18,19]. The PAM250 scoring matrix gives S38G a score of
+1 indicating that the amino acid replacement occurs 1.25 times as frequently as expected
by chance [20].
Splice site prediction did not reveal any variation in the splice sites due to the three
polymorphisms.
Hapmap was created for all the three polymorphisms to compare the allelic frequencies of
Indian population with other populations, which did not reveal any variation in the allelic
frequency distribution with respect to S546S and IVS13+36A>G SNPs (Figs. 6a & 6b).
However, complete lack of A allele of S38G in the Chinese and Malay populations was
observed, emphasizing the genetic diversity in Indian population (Fig. 6c).
Fig. 6. Hapmap of all the 3 polymorphisms
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4. DISCUSSION
The IKs channel is formed by co-assembly of KCNQ1 and KCNE1. The biophysical
properties of the KCNQ1 current are dramatically altered when its subunit associates with
KCNE1. In the presence of KCNE1, there is an increase in current amplitude, slow onset of
activation, depolarizing shift in the voltage dependence of activation, increase in single
channel conductance, removal of inactivation and control of deactivation kinetics by C-
terminus. Mutations in KCNQ1 or KCNE1 genes can act as biomarkers for life-threatening
cardiac arrhythmias such as long QT (LQT) or short QT syndromes [5,6,7,8,9]. S546S
(rs1057128) which is located in the KCNQ1 C-terminus close to assembly domain may affect
the functional protein [2]. The loss-of function effects of the KCNE1 S38G allele was
reported, to have the potential to predispose to early afterdepolarizations [21].
Our study revealed a higher female preponderance with the mean age being higher in
females when compared to males. But, the mean QTc interval was found to be higher in
males (493 ± 45.8) than female (476 ± 51.7) patients supporting the less affected sex to be
more prone to severity of the disease. Studies have reported the association of synonymous
variant rs1057128 (S546S) and nonsynonymous variant rs12720449 (P448R) of KCNQ1
with Long-QT syndrome in European and Chinese individuals [2]. The association of the rare
allele of IVS2-128 A and rs727957 T of KCNE1 gene associated with the prolongation of the
QTc length in healthy Caucasian subjects was also reported [9]. The two variations (S546S
and IVS13+36A>G) in KCNQ1 and the S38G polymorphism in KCNE1 gene identified in this
study is the first to report polymorphisms and their association with LQTS in the Indian
population.
The ‘AG’ genotypic frequency was found to be higher in controls when compared to LQTS
patients, with respect to all the three polymorphisms. The observations revealed a significant
association of ‘AG’ genotype of S546 and IVS13+36A>G with LQTS polymorphisms
(OR=0.36; 95%CI 0.15-0.89; p=0.014). Our study is in concordance with Chen et al [2] who
described the minor allele of S546 (rs1057128) to be significantly associated with decreased
TG (triglyceride) levels in Han subjects. Studies have reported KCNE1 S38G polymorphism
in healthy subjects in two different populations [21, 9]. The haplotype analysis indicated a
significant association of the ‘GGA’ haplotype (p<0.0001) with LQTS and a strong linkage
disequilibrium between the three polymorphisms based on LD analysis.
In-silico analysis of S546S polymorphism of KCNQ1 gene revealed an increase in free
energy of variant mRNA secondary structure which may lower its thermodynamic stability.
Splicing factor binding sites were found to vary for SRp40, NOVA1 with the formation of a
new binding site for QK1 motif. The variations predicted in mRNA secondary structure and
splicing factor binding sites may affect gene regulation with possible variations in protein
structure and function due to bias in codon usage [2]. As per previous studies, a small
domain between residues 589 and 620 in the KCNQ1 C-terminus may function as an
assembly domain for KCNQ1 subunits. In the absence of this domain, KCNQ1 C-termini fail
to assemble, and functional potassium channels are not produced [2]. Since, S546S is
located in the KCNQ1 C-terminus close to this domain, it may affect the functional protein
through non-assembly. Our results indicate that this synonymous variation can also affect
the thermodynamic stability of mRNA secondary structures and splicing factor binding sites,
therefore, synonymous mutations may not be neutral in evolution but may have a critical role
in protein folding and chaperoning.
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The intronic variation IVS13+36A>G of KCNQ1 gene reported by Koo et al [17] in healthy
subjects leads to a loss of stem-4 and the formation of an aberrant stem-3 in the variant as
indicated by mRNA secondary structure prediction. The IVS13+36A>G SNP variant allele
caused variations in the splicing factor binding sites for SF2ASF, SC35 and hnRNPH/F
motifs. Since, this polymorphism is located in the intronic region in close proximity to the
coding region for C-terminal domain; the mRNA secondary structure and splicing factor
binding site predicted variations may influence the C-termini of the protein.
mRNA secondary structure prediction of S38G SNP of KCNE1 gene indicated that the
variation lead to an increase in the free energy of stem 4 of secondary structure of mRNA
thus decreasing the thermodynamic stability. This polymorphism leads to a substitution of
serine by glycine at 38th amino acid position (S38G) in the transmembrane domain of
KCNE1. A polar, hydrophilic, essential serine is replaced by non-polar, hydrophobic, non-
essential glycine. It has been shown that the transmembrane region of KCNE1 binds directly
to the pore region of KCNQ1 to regulate channel activity [3,5,6]. Hence, this substitution may
lead to variations in the stoichiometry of KCNQ1 and KCNE1 complex finally leading to
variations in repolarisation by the potassium channel.
Our study reports compound heterozygosity/genetic compound ofS546S and IVS13+36A>G
of KCNQ1 gene. This phenomenon can lead to the interaction of the two polymorphisms
which might further lead to variation in the KCNQ1 potassium channel. Further functional
and large cohort studies are required to dissect the mechanisms of KCNQ1-KCNE1 gating
and may lead to the discovery of a potent activator of Q1/E1 complexes for the treatment of
cardiac arrhythmias.
5. CONCLUSION
A significant association of KCNQ1 gene S546S and IVS13+36A>G polymorphisms with
Long QT syndrome in the Indian population is being reported. These polymorphisms can be
developed as biomarkers for LQTS. Haplotype frequencies and linkage disequilibrium
analysis revealed a significant association between the three biomarkers. Compound
heterozygosity of the polymorphisms influence downstream signalling and KCNQ1-KCNE1
interactions.
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